GB1577647A - Prostaglandins - Google Patents
Prostaglandins Download PDFInfo
- Publication number
- GB1577647A GB1577647A GB7981/77A GB798177A GB1577647A GB 1577647 A GB1577647 A GB 1577647A GB 7981/77 A GB7981/77 A GB 7981/77A GB 798177 A GB798177 A GB 798177A GB 1577647 A GB1577647 A GB 1577647A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxo
- trans
- cis
- lysergyl
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH526876 | 1976-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1577647A true GB1577647A (en) | 1980-10-29 |
Family
ID=4290745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB7981/77A Expired GB1577647A (en) | 1976-04-27 | 1977-02-25 | Prostaglandins |
Country Status (13)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU196598B (en) * | 1986-04-25 | 1988-12-28 | Richter Gedeon Vegyeszet | Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds |
-
1977
- 1977-02-21 DK DK75177A patent/DK75177A/da unknown
- 1977-02-22 FI FI770572A patent/FI770572A7/fi not_active Application Discontinuation
- 1977-02-24 DE DE19772707915 patent/DE2707915A1/de not_active Withdrawn
- 1977-02-25 GB GB7981/77A patent/GB1577647A/en not_active Expired
- 1977-02-28 NZ NZ183462A patent/NZ183462A/xx unknown
- 1977-02-28 IL IL51561A patent/IL51561A0/xx unknown
- 1977-03-01 ZA ZA00771215A patent/ZA771215B/xx unknown
- 1977-03-02 NL NL7702221A patent/NL7702221A/nl not_active Application Discontinuation
- 1977-03-03 PT PT66269A patent/PT66269B/pt unknown
- 1977-03-03 SU SU772457126A patent/SU741794A3/ru active
- 1977-03-03 BE BE175449A patent/BE852055A/xx unknown
- 1977-03-03 FR FR7706181A patent/FR2353549A1/fr not_active Withdrawn
- 1977-03-03 JP JP2225977A patent/JPS52131600A/ja active Pending
- 1977-08-30 FR FR7726295A patent/FR2355837A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| SU741794A3 (ru) | 1980-06-15 |
| PT66269B (en) | 1978-11-07 |
| ZA771215B (en) | 1978-10-25 |
| DE2707915A1 (de) | 1977-11-17 |
| FI770572A7 (enrdf_load_stackoverflow) | 1977-10-28 |
| PT66269A (en) | 1977-04-01 |
| NZ183462A (en) | 1979-10-25 |
| JPS52131600A (en) | 1977-11-04 |
| FR2355837A1 (fr) | 1978-01-20 |
| IL51561A0 (en) | 1977-04-29 |
| DK75177A (da) | 1977-10-28 |
| NL7702221A (nl) | 1977-10-31 |
| BE852055A (fr) | 1977-09-05 |
| FR2353549A1 (fr) | 1977-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0388948B1 (en) | Acryloyl substituted pyrrole derivatives | |
| RU95112848A (ru) | Гетеробициклические производные сульфонамида и сульфонового эфира, способы получения, антиопухолевое средство, фармакологическая композиция, способ лечения | |
| US4532344A (en) | Fluoranthene derivatives | |
| IE870995L (en) | Amino-thiazole and oxazole derivatives | |
| EA014689B1 (ru) | Новые соединения - аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат | |
| US6307068B1 (en) | Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same | |
| KR100259309B1 (ko) | 항-hiv 활성을 갖는 이미다졸 유도체 | |
| AU619766B2 (en) | 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present | |
| EP0272478B1 (en) | Glycyrrhetic acid derivatives and use thereof | |
| FR2549061A1 (fr) | Derives du spirosuccinimide utilisables comme medicaments | |
| GB1577647A (en) | Prostaglandins | |
| EP1101765B1 (fr) | Nouveaux composés analogues de la camptothécine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| US4157340A (en) | N,N'-[Bis(N-cyanoguanyl)]cystamine derivatives | |
| FR2551065A1 (fr) | Composes analogues a des prostaglandines, du type thiocarbamate a substituant 7-oxabicycloheptane et leurs applications therapeutiques, notamment dans le traitement de la maladie thrombolytique | |
| US4249001A (en) | Prostanoic ergolin-8-yl esters, thioesters, and amides | |
| CA2237401C (en) | Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides | |
| EP0310109A2 (en) | Novel aminoalkyl-substituted heterocyclic sulfur compounds | |
| WO2005023817A1 (fr) | Derives de 9-amino-podophyllotoxine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| US5151437A (en) | Benzofurancarboxamides having basic substituents and therapeutic agents containing the same | |
| EP0405525B1 (en) | Novel cyanoguanidine derivatives | |
| EP0319576B1 (en) | Prostaglandin derivatives, processes for preparing them and pharmaceutical compositions containing said derivatives | |
| US5318975A (en) | 5-pyrimdineamine derivatives | |
| HU183382B (en) | Process for preparing ergoline derivatives and pharmaceutical compositions containing thereof as active substances | |
| US5356901A (en) | Benzofurancarboxamides having basic substituents, the preparation thereof, and therapeutic agents containing them | |
| EP1910376B1 (fr) | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CSNS | Application of which complete specification have been accepted and published, but patent is not sealed |